• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRICLIP G4 SYSTEM; TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRICLIP G4 SYSTEM; TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number TCDS0301-XTW
Medical Device Problem Code Difficult to Remove (1528)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/01/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported that a triclip procedure was performed to treat functional tricuspid regurgitation (tr) with a grade of 4 on a patient with a prominent eustachian valve.A triclip steerable guide catheter and a triclip was inserted.However, the device was interacting with the eustachian valve in a way that was preventing the ability to steer and manipulate the clip delivery system (cds) as intended.Due to these challenges, difficulty understraddling the clip back into the guide occurred, but were finally able to get the clip back into the guide.Therefore, the tsgc and cds were removed from the patient.The tsgc was inspected, and there was no damage observed.Therefore, a new tsgc and a new triclip was used to complete the procedure.One clip was implanted, reducing tr to a grade of 1.There were no adverse patient effects and no clinically significant delay in the procedure.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.Based on available information, the reported difficult to remove cds from sgc was likely due to procedural circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event or Problem Description
Subsequent to the previously filed report, additional clarified information was received: it was reported that a triclip procedure was performed to treat functional tricuspid regurgitation (tr) with a grade of 4 on a patient with a prominent eustachian valve.A triclip was inserted and deployed on the tricuspid valve.A second clip, a triclip was then inserted and steered down to the valve.However, there was very little height above the valve and difficult trajectory.An attempt to open and orient the clip was made, but the clip ended up under one of the leaflets.The clip was inverted and brought back to the right atrium (ra).Troubleshooting was performed, but the clip was still unable to be achieve a good position.After several attempts, the clip was retracted back into the steerable guide catheter (sgc).However, it was observed that the sgc was interacting with the eustachian valve in a way that was preventing the ability to steer and manipulate the clip delivery system (cds) as intended.Due to these challenges, difficulty understradling the clip back into the tscg occurred.Several attempts were made to get the clip back into the sgc, and the clip was ultimately able to get back into the tsgc.Therefore, a decision was made to remove the clip and tsgc.The clip and the tsgc were removed and replaced.A new tsgc and a new clip were then inserted and deployed on the tricuspid valve, reducing tr to a grade of 1.While outside of the patient, the tsgc was inspected, and there was no damage observed.There were no adverse patient effects and no clinically significant delay in the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRICLIP G4 SYSTEM
Common Device Name
TRICUSPID VALVE REPAIR DEVICE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23889872
Report Number2135147-2025-07710
Device Sequence Number11929463
Product Code NPS
UDI-Device Identifier05415067047755
UDI-Public(01)05415067047755(17)260820(10)50821R1067
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
P230007
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/20/2026
Device Model NumberTCDS0301-XTW
Device Catalogue NumberTCDS0301-XTW
Device Lot Number50821R1067
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/01/2025
Supplement Date Received by Manufacturer02/05/2026
Initial Report FDA Received Date12/24/2025
Supplement Report FDA Received Date02/18/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/21/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age87 YR
Patient SexFemale
-
-